Search Results - "Smith, B. P"

Refine Results
  1. 1

    Challenges and Opportunities in Rare Disease Drug Development by Smith, BP

    Published in Clinical pharmacology and therapeutics (01-10-2016)
    “…Each month, Clinical Pharmacology & Therapeutics focuses on a particular theme. Twice a year, the associate editors, editors, and staff get together to discuss…”
    Get full text
    Journal Article
  2. 2

    A systematic review of randomized controlled trials for the prevention of bronchopulmonary dysplasia in infants by Beam, K S, Aliaga, S, Ahlfeld, S K, Cohen-Wolkowiez, M, Smith, P B, Laughon, M M

    Published in Journal of perinatology (01-09-2014)
    “…Objective: Bronchopulmonary dysplasia (BPD) is the most common cause of pulmonary morbidity in premature infants and is associated with life-long morbidities…”
    Get full text
    Journal Article
  3. 3

    Impediments to Clinical Research in the United States by Kramer, J M, Smith, P B, Califf, R M

    Published in Clinical pharmacology and therapeutics (01-03-2012)
    “…Clinical trials are essential to the evaluation of promising scientific discoveries, but they are becoming unsustainably burdensome, threatening to deprive…”
    Get full text
    Journal Article
  4. 4

    Safety and Pharmacokinetics of Multiple-Dose Anidulafungin in Infants and Neonates by Cohen‐Wolkowiez, M, Benjamin, DK, Piper, L, Cheifetz, IM, Moran, C, Liu, P, Aram, J, Kashuba, ADM, Capparelli, E, Walsh, TJ, Hope, WW, Smith, PB

    Published in Clinical pharmacology and therapeutics (01-05-2011)
    “…Candida infections are common and often fatal in infants and neonates. Anidulafungin has excellent activity against Candida species, but the pharmacokinetics…”
    Get full text
    Journal Article
  5. 5

    Safety and Pharmacokinetics of Repeat-Dose Micafungin in Young Infants by Benjamin, D K, Smith, P B, Arrieta, A, Castro, L, Sánchez, P J, Kaufman, D, Arnold, L J, Kovanda, L L, Sawamoto, T, Buell, D N, Hope, W W, Walsh, T J

    Published in Clinical pharmacology and therapeutics (01-01-2010)
    “…Given the risk of central nervous system infection, relatively high weight‐based echinocandin dosages may be required for the successful treatment of invasive…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Antenatal methadone vs buprenorphine exposure and length of hospital stay in infants admitted to the intensive care unit with neonatal abstinence syndrome by Tolia, V N, Murthy, K, Bennett, M M, Miller, E S, Benjamin, D K, Smith, P B, Clark, R H

    Published in Journal of perinatology (01-01-2018)
    “…Objective: Antenatal exposure to methadone or buprenorphine often causes neonatal abstinence syndrome (NAS) in newborns. However, comparative effects on…”
    Get full text
    Journal Article
  9. 9

    Arid Coastal Carbonates and the Phanerozoic Record of Carbonate Chemistry by Smith, B. P., Cantine, M. D., Bergmann, K. D., Ramos, E. J., Martindale, R. C., Kerans, C.

    Published in AGU advances (01-09-2021)
    “…Ocean chemistry and carbonate sedimentation link Earth's climate, carbon cycle, and marine pH. The carbonate system in seawater is complex and there are large…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Geochemical modelling of the evolution and fate of metal pollutants arising from an abandoned gold mine tailings facility in Johannesburg by CAMDEN-SMITH, B. P. C, TUTU, H

    Published in Water science and technology (01-01-2014)
    “…Analytical techniques were combined with geochemical modelling to study the release mechanisms of pollutants from an abandoned gold mining tailings storage…”
    Get full text
    Journal Article
  12. 12

    Motor cortical functional geometry in cerebral palsy and its relationship to disability by Kesar, T.M, Sawaki, L, Burdette, J.H, Cabrera, M.N, Kolaski, K, Smith, B.P, O’Shea, T.M, Koman, L.A, Wittenberg, G.F

    Published in Clinical neurophysiology (01-07-2012)
    “…Highlights ► In cerebral palsy patients, for the first time, we demonstrate hand maps lateral to the expected location, and replicate the finding of…”
    Get full text
    Journal Article
  13. 13

    Fluconazole pharmacokinetics and safety in premature infants by Turner, K, Manzoni, P, Benjamin, D K, Cohen-Wolkowiez, M, Smith, P B, Laughon, M M

    Published in Current medicinal chemistry (2012)
    “…Invasive candidiasis (IC) in the premature infant population is a common infection that results in substantial morbidity and mortality. For these patients,…”
    Get more information
    Journal Article
  14. 14

    Ignorance is not bliss: Statistical power is not probability of trial success by Zierhut, ML, Bycott, P, Gibbs, MA, Smith, BP, Vicini, P

    Published in Clinical pharmacology and therapeutics (01-04-2016)
    “…The purpose of this commentary is to place probability of trial success, or assurance, in the context of decision making in drug development, and to illustrate…”
    Get full text
    Journal Article
  15. 15

    Confidence interval criteria for assessment of dose proportionality by SMITH, Brian P, VANDENHENDE, Francois R, DESANTE, Karl A, FARID, Nagy A, WELCH, Pamela A, CALLAGHAN, John T, FORGUE, S. Thomas

    Published in Pharmaceutical research (01-10-2000)
    “…The aim of this work was a pragmatic, statistically sound and clinically relevant approach to dose-proportionality analyses that is compatible with common…”
    Get full text
    Journal Article
  16. 16

    Pharmacokinetics, Safety, and Tolerability of Atomoxetine and Effect of CYP2D610/10 Genotype in Healthy Japanese Men by Matsui, A., Azuma, J., Witcher, J. W., Long, A. J., Sauer, J.-M., Smith, B. P., DeSante, K. A., Read, H. A., Takahashi, M., Nakano, M.

    Published in Journal of clinical pharmacology (01-03-2012)
    “…Atomoxetine is a cytochrome P4502D6 (CYP2D6) substrate. The reduced-activity CYP2D6*10 allele is particularly prevalent in the Japanese population and may…”
    Get full text
    Journal Article
  17. 17

    Cough in Pediatric Patients Receiving Angiotensin-Converting Enzyme Inhibitor Therapy or Angiotensin Receptor Blocker Therapy in Randomized Controlled Trials by Baker‐Smith, C M, Benjamin, D K, Califf, R M, Murphy, M D, Li, J S, Smith, P B

    Published in Clinical pharmacology and therapeutics (01-06-2010)
    “…The incidence of cough in children receiving antihypertension therapy with angiotensin‐converting enzyme inhibitors (ACEis) or angiotensin receptor blockers…”
    Get full text
    Journal Article
  18. 18

    Racial Differences in Blood Pressure Response to Angiotensin-Converting Enzyme Inhibitors in Children: A Meta-Analysis by Li, JS, Baker‐Smith, CM, Smith, PB, Hasselblad, V, Murphy, MD, Califf, RM, Benjamin, DK

    Published in Clinical pharmacology and therapeutics (01-09-2008)
    “…Angiotensin‐converting enzyme (ACE) inhibitors are frequently used to treat hypertension in children.1 ACE inhibitors alter the balance between the…”
    Get full text
    Journal Article
  19. 19

    Tracing energy inputs into the seafloor using carbonate sediments by Smith, B P, Edie, S M, Fischer, W W

    “…Carbonate rocks provide unique and valuable sedimentary archives for secular changes in Earth's physical, chemical, and biological processes. However, reading…”
    Get full text
    Journal Article
  20. 20

    Cartilage injuries: a review of 31,516 knee arthroscopies by Curl, W W, Krome, J, Gordon, E S, Rushing, J, Smith, B P, Poehling, G G

    Published in Arthroscopy (01-08-1997)
    “…Although articular cartilage injuries of the knee are common, injured cartilage has a limited ability to heal. Recent data suggest that articular cartilage…”
    Get more information
    Journal Article